Study Title: Phase II Study of Pembrolizumab in Combination With Carboplatin and Paclitaxel for Advanced or Recurrent Endometrial Adenocarcinoma
 

• Status: Completed 
• Participating institutions:
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center
  • Holden Comprehensive Cancer Center, University of Iowa
  • Masonic Cancer Center, University of Minnesota
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Ironwood Cancer and Research Centers
• Learn more:
  • clinicaltrials.gov: NCT02549209
  • Big Ten CRC News Release
• Publications and Presentations:
  • Poster Discussion: 2020 ASCO Annual Meeting